CMAJ • June 23, 2009; 180 (13). doi:10.1503/cmaj.081214.
© 2009 Canadian Medical Association or its licensors
All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association.
This Article
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rehman, H. u.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rehman, H. u.
Related Collections
Right arrow Other cancers
Right arrowRelated Articles


Practice

Clinical images

Carcinoid syndrome

Habib ur Rehman, MBBS

From the Department of Internal Medicine, Regina General Hospital, Regina Qu’Appelle Health Region, Regina, Sask.

A 72-year-old man was admitted to hospital with congestive heart failure, weight loss and chronic diarrhea. He had flushing of the face and cyanosis, and telangiectasia were present in the cheek area (Figure 1).


Figure 117
View larger version (124K):
[in this window]
[in a new window]

 
Figure 1: A 72-year-old man with carcinoid syndrome, showing flushing, cyanosis and telangiectasia.

 

A contrast-enhanced computed tomography scan of the liver showed multiple masses with ring enhancement that were compatible with metastases (Figure 2). An echocardiogram showed right-sided dilation of the heart with severe tricuspid regurgitation. The patient’s aortic, mitral and pulmonic valves were normal in structure and function. A 24-hour urine collection showed a total output of 5-hydroxyindoleacetic acid of 1515 (normal 0–43) µmol/L. A biopsy of the liver with immunostaining for chromogranin and synaptophysin were strongly positive and confirmed a diagnosis of metastatic carcinoid syndrome. The patient died 4 months later.


Figure 217
View larger version (55K):
[in this window]
[in a new window]

 
Figure 2: Contrast-enhanced computed tomography scan of the liver showing numerous masses compatible with metastases.

 

A carcinoid tumour is a rare neuroendocrinologic malignancy that commonly originates from enterochromaffin cells in the gastrointestinal tract. The rate of incidence of carcinoid tumours has increased from 1.09 cases per 100 000 in 1973 to 5.25 cases per 100 000 in 2004, with a median age at diagnosis of 63 years. 1 This increase has likely resulted from improvements in the classification of such tumours and from more widespread use of certain diagnostic screening tools such as endoscopy. Carcinoid syndrome occurs when cells from the tumour metastasize to the liver and vasoactive substances enter systemic circulation via the hepatic vein. Flushing involving the face and upper trunk are the most prominent cutaneous signs. Telangiectasias may also develop. Flushing may be worsened by the consumption of hot foods and beverages, chocolate, spicy foods, tomatoes, alcohol and cheeses or by emotional stress. 2 As many as 20% of patients with carcinoid syndrome present with carcinoid heart disease at diagnosis. Echocardiographic abnormalities, commonly involving the tricuspid valve, are found in up to 70% of patients. 3,4 The median duration of survival is 124 months for patients with neuroendocrine tumours at the grade 1 stage, 64 months for those with grade 2 tumours and 10 months for those with grade 3 or 4 tumours.


*    REFERENCES
 Top
 REFERENCES
 

  1. Yao JC, Hassan M, Phan A, et al. One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 2008;26:3063–72.[Abstract/Free Full Text]
  2. Sabir S, James WD, Schuchter LM. Cutaneous manifestations of cancer. Curr Opin Oncol 1999;11:139–44.[CrossRef][Medline]
  3. Bhattacharyya S, Davar J, Dreyfus G, et al. Carcinoid heart disease. Circulation 2007;116:2860–5.[Free Full Text]
  4. Pellikka PA, Tajik AJ, Khandheria BK, et al. Carcinoid heart disease: clinical and echocardiographic spectrum in 74 patients. Circulation 1993;87:1188–96.[Abstract/Free Full Text]

Related Articles

Highlights
Can. Med. Assoc. J. 2009 180: 1277. [Full Text] [PDF]

Dans ce numéro
Can. Med. Assoc. J. 2009 180: E109. [Full Text] [PDF]




This Article
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rehman, H. u.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rehman, H. u.
Related Collections
Right arrow Other cancers
Right arrowRelated Articles